News About: Pharm. Industry
KFDA Issues Revised Market Approval Specification for Gemzar
The Korea Food and Drug Administration (KFDA) recently issued a revised approval specification for Lilly Korea's Gemzar Inj. 200mg (active ingredient: gemcitabine hydrochloride), a chemotherapy drug for treatment of c...
OTC Advertisement at Television Homeshopping Channel
Haewae Trading Corp., a domestic import/export company specialized in the distribution and marketing of various pharmaceutical and other health-related products, is currently looking to invite pharmaceutical firms to ...
MSD Korea to Move Away from Exclusive Distribution Strategy
The multinational pharmaceutical firms that have made an exclusive distribution outsourcing agreement with Zuellig Pharma Korea (ZPK) are looking to modify their existing sales and distribution strategies to include o...
Daewoong's Nicostop Faces with Surging Demand
As more people are making their health-conscious decisions to quit smoking for the new year, the respective demand level for Nicostop, the leading nicotine replacement product in the domestic market, has been fast inc...
Anticancer Treatment Developed with Patented Drug Delivery System Now Available
Daewoong Pharmaceutical recently announced the launching of Lupier Depot (active ingredient: leuprolide acetate) in the domestic market, using the novel drug delivery system (DDS) technology developed by Peptron Inc.,...
136 Pharmaceutical Products Identified with Over 10 Billion Won of Individual Sales
The statistical analysis on actual Year 2004 pharmaceuticals sales data in the domestic market shows that there were 136 individual products from 44 different pharmaceutical firms that recorded 10 billion won or above...
Dong-A Posts Year 2004 Revenue of 541 Billion Won
Dong-A Pharmaceutical reported its total revenue for Year 2004 at 541.2 billion won, which is an increase of 9.89% from the prior fiscal year of 492.5 billion won.
Both the operating profit and the ordinary profit ...
Recent Pilot Study Shows Tibolone is Effective for Postmenopausal Symptoms
Results from a European study indicate tibolone is an effective hormone replacement therapy (HRT) to alleviate postmenopausal symptoms, such as hot flushes and night sweats, for patients recovering from breast cancer ...
Insurance Coverage for MSD Korea's Singulair Now Expanded
Effective February 1st, the National Health Insurance (NHI) eligible coverage for MSD Korea's Singulair, a leukotriene receptor antagonist medication primarily indicated for prevention and treatment of asthma symptoms...
Domestic Manufacturers Aim to Realize Faster Market Share Gains for First Generics
The domestic pharmaceutical firms are increasing their efforts to gain the first-hand competitive advantages by executing faster introductions of the first generic products in the market.
The firms collectively mak...
